210 related articles for article (PubMed ID: 30276563)
1. Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases.
Zhang W; Wang F; Wang H; Hua B; Feng X; Sun L
Clin Rheumatol; 2018 Dec; 37(12):3337-3344. PubMed ID: 30276563
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.
Wu C; Wang Q; Xu D; Li M; Zeng X
Rheumatology (Oxford); 2021 Jun; 60(6):2629-2634. PubMed ID: 33200217
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag in severe immune thrombocytopenia secondary to connective tissue disease: a report of 17 patients and literature review.
Li W; Wang D; Ma L; Zhu Y; Wang F; Hua B; Wang H; Feng X
Clin Rheumatol; 2023 May; 42(5):1451-1457. PubMed ID: 36593363
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study.
Du H; Su W; Su J; Hu J; Wu D; Long W; Zhu J
Rheumatology (Oxford); 2024 Jan; 63(1):79-84. PubMed ID: 37079730
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yasuoka H; Shirai Y; Tamura Y; Takeuchi T; Kuwana M
Circ J; 2018 Jan; 82(2):546-554. PubMed ID: 28904255
[TBL] [Abstract][Full Text] [Related]
7. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
8. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
Jovancevic B; Lindholm C; Pullerits R
Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
[TBL] [Abstract][Full Text] [Related]
9. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
[TBL] [Abstract][Full Text] [Related]
11. Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis?
Tunc SE; Ertam I; Pirildar T; Turk T; Ozturk M; Doganavsargil E
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):497-503. PubMed ID: 17373977
[TBL] [Abstract][Full Text] [Related]
12. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].
Ji YQ; Zhang ZL; Lu WX
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):467-71. PubMed ID: 16831323
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
Lin CY; Ko CH; Hsu CY; Chen HA
Semin Arthritis Rheum; 2020 Oct; 50(5):957-962. PubMed ID: 32906031
[TBL] [Abstract][Full Text] [Related]
14. The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus.
Lee CT; Strek ME
Curr Opin Pulm Med; 2021 Sep; 27(5):388-395. PubMed ID: 34127620
[TBL] [Abstract][Full Text] [Related]
15. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of low-dose rituximab on hematological abnormalities in patients with connective tissue disease
.
Wang CY; Guo SH; Wang LP; Wang XY; Shen HL
Int J Clin Pharmacol Ther; 2019 Oct; 57(10):500-505. PubMed ID: 31426902
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome.
Nossent JC; Swaak AJ
Lupus; 1998; 7(4):231-4. PubMed ID: 9643312
[TBL] [Abstract][Full Text] [Related]
18. [Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus].
Guo Q; Ma XX; Gao H; Shi LJ; Zhong YC; Xie LF; Shao M; Zhang XW
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):892-896. PubMed ID: 33047725
[TBL] [Abstract][Full Text] [Related]
19. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
20. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
